SpyGlass Pharma, Inc. (SGP) — Defensive Interval Ratio

Latest as of March 2026: 698 days

SpyGlass Pharma, Inc. (SGP) has a Defensive Interval Ratio of 698 days as of March 2026. Defensive assets of $12.75 Million (cash $-, short-term investments $12.10 Million, receivables $653.00K) cover 698 days of daily cash needs of $18.27K/day. See working capital to net assets of SpyGlass Pharma, Inc. to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

698 days
Days of operational coverage

Defensive Assets

$12.75 Million
Cash + ST Investments + Receivables

Daily Cash Need

$18.27K
Current Liabilities ÷ 365

Current Liabilities

$6.67 Million
USD

SpyGlass Pharma, Inc. Defensive Interval Ratio (2023–2025)

This chart shows how SpyGlass Pharma, Inc.'s Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the ratio stands at 698 days, meaning defensive assets of $12.75 Million can fund 698 days of operations without new revenue. See SGP net asset quality score to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for SpyGlass Pharma, Inc. (2023–2025)

The table below presents the year-by-year Defensive Interval Ratio for SpyGlass Pharma, Inc. from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see SGP stock market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 489 days $11.51 Million $23.52K/day $- $11.08 Million ▲ +489 days
2024 0 days $0.00 $21.35K/day $- $0.00 ▼ -5622 days
2023 5622 days $24.47 Million $4.35K/day $- $24.47 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)